Grant: Centres of Excellence for Commercialization and Research (CECR)
Direct Payment
$10,515,000.00
C3i - Centre for commercialization of Cancer Immunotherapy
EF 2015-16
Programme
Centres of Excellence for Commercialization and Research (CECR)
Bénéficiaire
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
338079
Name
Busque Lambert
Region
Québec
Country
Canada
Orgtype
Research Institution
Partnername
Social Sciences & Humanities Research Council (Ottawa, Ontario); Natural Sciences and Engineering Research Council of Canada (NSERC); Centre for Commercialization of Cancer Immunotherapy (Montreal, QC)
Prcname2
Special Cases
Projecttitle
C3i - Centre for commercialization of Cancer Immunotherapy
Programtype2
Operating Grants
Orgnameinp2
Direct Payment
Cihramount2
$10,515,000
Cihrequipment2
$0
Programname2
Centres of Excellence for Commercialization and Research (CECR)
Keyworddelim
Biomarkers; Cancer; Cell Therapy; Commercialization; Gmp; Gmp Clinical Research; Immunotherapy; Lean; Next Generation Sequencing; Pd-1
Competitiondate
201508
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Busque, Lambert
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $10,515,000~ $0~
